BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27658761)

  • 21. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
    Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
    J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overview of 15-year severe combined immunodeficiency in the Netherlands: towards newborn blood spot screening.
    de Pagter AP; Bredius RG; Kuijpers TW; Tramper J; van der Burg M; van Montfrans J; Driessen GJ;
    Eur J Pediatr; 2015 Sep; 174(9):1183-8. PubMed ID: 25875249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. How I treat severe combined immunodeficiency.
    Gaspar HB; Qasim W; Davies EG; Rao K; Amrolia PJ; Veys P
    Blood; 2013 Nov; 122(23):3749-58. PubMed ID: 24113871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
    Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
    Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The different extent of B and T cell immune reconstitution after hematopoietic stem cell transplantation and enzyme replacement therapies in SCID patients with adenosine deaminase deficiency.
    Serana F; Sottini A; Chiarini M; Zanotti C; Ghidini C; Lanfranchi A; Notarangelo LD; Caimi L; Imberti L
    J Immunol; 2010 Dec; 185(12):7713-22. PubMed ID: 21057082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
    Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
    Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe combined immunodeficiencies and related disorders.
    Fischer A; Notarangelo LD; Neven B; Cavazzana M; Puck JM
    Nat Rev Dis Primers; 2015 Oct; 1():15061. PubMed ID: 27189259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hematopoietic Stem Cell Transplantation in Primary Immunodeficiencies Beyond Severe Combined Immunodeficiency.
    Freeman AF
    J Pediatric Infect Dis Soc; 2018 Dec; 7(suppl_2):S79-S82. PubMed ID: 30590619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99.
    Antoine C; Müller S; Cant A; Cavazzana-Calvo M; Veys P; Vossen J; Fasth A; Heilmann C; Wulffraat N; Seger R; Blanche S; Friedrich W; Abinun M; Davies G; Bredius R; Schulz A; Landais P; Fischer A; ;
    Lancet; 2003 Feb; 361(9357):553-60. PubMed ID: 12598139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-Center Study of 72 Patients with Severe Combined Immunodeficiency: Clinical and Laboratory Features and Outcomes.
    Bayram O; Haskologlu S; Bayrakoğlu D; Bal SK; Islamoglu C; Cipe FE; Kendirli T; Kursun N; Guner SN; Yildiran A; Bozdogan G; Yuksek M; Reisli I; Dalva K; Aytekin C; Boztug K; Dogu F; Ikinciogullari A
    J Clin Immunol; 2021 Oct; 41(7):1563-1573. PubMed ID: 34114123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral T Cells for Adenovirus in the Pretransplant Period: A Bridge Therapy for Severe Combined Immunodeficiency.
    Miller HK; Hanley PJ; Lang H; Lazarski CA; Chorvinsky EA; McCormack S; Roesch L; Albihani S; Dean M; Hoq F; Adams RH; Bollard CM; Keller MD
    Biol Blood Marrow Transplant; 2018 Sep; 24(9):1944-1946. PubMed ID: 29753156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systematic neonatal screening for severe combined immunodeficiency and severe T-cell lymphopenia: Analysis of cost-effectiveness based on French real field data.
    Clément MC; Mahlaoui N; Mignot C; Le Bihan C; Rabetrano H; Hoang L; Neven B; Moshous D; Cavazzana M; Blanche S; Fischer A; Audrain M; Durand-Zaleski I
    J Allergy Clin Immunol; 2015 Jun; 135(6):1589-93. PubMed ID: 25840725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BCG Moreau Vaccine Safety Profile and NK Cells-Double Protection Against Disseminated BCG Infection in Retrospective Study of BCG Vaccination in 52 Polish Children with Severe Combined Immunodeficiency.
    Bernatowska E; Skomska-Pawliszak M; Wolska-Kuśnierz B; Pac M; Heropolitanska-Pliszka E; Pietrucha B; Bernat-Sitarz K; Dąbrowska-Leonik N; Bohynikova N; Piątosa B; Lutyńska A; Augustynowicz E; Augustynowicz-Kopeć E; Korzeniewska-Koseła M; Krasińska M; Krzysztopa-Grzybowska K; Wieteska-Klimczak A; Książyk J; Jackowska T; van den Burg M; van Dongen JJM; Casanova JL; Picard C; Mikołuć B
    J Clin Immunol; 2020 Jan; 40(1):138-146. PubMed ID: 31749033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Transplantation of genetically modified cells in the treatment of children with SCID: great hopes and recent disappointments].
    Smogorzewska EM; Weinberg KI; Kohn DB
    Med Wieku Rozwoj; 2003; 7(1):27-34. PubMed ID: 13130167
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoietic stem cell transplantation for severe combined immunodeficiency.
    Hönig M; Schulz A; Friedrich W
    Klin Padiatr; 2011 Nov; 223(6):320-5. PubMed ID: 22052630
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Juvenile Metachromatic Leukodystrophy Compared With Nontransplanted Control Patients.
    Groeschel S; Kühl JS; Bley AE; Kehrer C; Weschke B; Döring M; Böhringer J; Schrum J; Santer R; Kohlschütter A; Krägeloh-Mann I; Müller I
    JAMA Neurol; 2016 Sep; 73(9):1133-40. PubMed ID: 27400410
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Matched unrelated bone marrow transplant for T+ combined immunodeficiency.
    Roifman CM; Somech R; Grunebaum E
    Bone Marrow Transplant; 2008 Jun; 41(11):947-52. PubMed ID: 18264145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Successful haploidentical hematopoietic stem cell transplantation in a patient with SCID due to CD3ε deficiency: need for IgG-substitution 6 years later.
    Fuehrer M; Pannicke U; Schuetz C; Jacobsen EM; Schulz A; Friedrich W; Schwarz K; Hönig M
    Klin Padiatr; 2014 May; 226(3):149-53. PubMed ID: 24515816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized hematopoietic stem cell transplantation for inborn errors of immunity.
    Slatter M; Lum SH
    Front Immunol; 2023; 14():1162605. PubMed ID: 37090739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.